WO2005112542A3 - Composición para la reparación ósea y cartilaginosa - Google Patents

Composición para la reparación ósea y cartilaginosa Download PDF

Info

Publication number
WO2005112542A3
WO2005112542A3 PCT/ES2005/000287 ES2005000287W WO2005112542A3 WO 2005112542 A3 WO2005112542 A3 WO 2005112542A3 ES 2005000287 W ES2005000287 W ES 2005000287W WO 2005112542 A3 WO2005112542 A3 WO 2005112542A3
Authority
WO
WIPO (PCT)
Prior art keywords
cartilage
cells
bone repair
repair composition
employed
Prior art date
Application number
PCT/ES2005/000287
Other languages
English (en)
French (fr)
Other versions
WO2005112542A2 (es
Inventor
Ratia Jose Becerra
Gomez Jose Antonio Andrades
Rueda Manuel Cifuentes
Parra Enrique Guerado
Original Assignee
Univ Malaga
Ratia Jose Becerra
Gomez Jose Antonio Andrades
Rueda Manuel Cifuentes
Parra Enrique Guerado
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Malaga, Ratia Jose Becerra, Gomez Jose Antonio Andrades, Rueda Manuel Cifuentes, Parra Enrique Guerado filed Critical Univ Malaga
Priority to MXPA06013492A priority Critical patent/MXPA06013492A/es
Priority to AU2005244626A priority patent/AU2005244626A1/en
Priority to JP2007517309A priority patent/JP2007538055A/ja
Priority to US11/597,236 priority patent/US20080031915A1/en
Priority to BRPI0510829-2A priority patent/BRPI0510829A/pt
Priority to EP05750573A priority patent/EP1760144A2/en
Priority to NZ552180A priority patent/NZ552180A/en
Priority to CA002567314A priority patent/CA2567314A1/en
Publication of WO2005112542A2 publication Critical patent/WO2005112542A2/es
Publication of WO2005112542A3 publication Critical patent/WO2005112542A3/es
Priority to IL179442A priority patent/IL179442A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0655—Chondrocytes; Cartilage
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1841—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02—Inorganic materials
    • A61L27/12—Phosphorus-containing materials, e.g. apatite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3817—Cartilage-forming cells, e.g. pre-chondrocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3821—Bone-forming cells, e.g. osteoblasts, osteocytes, osteoprogenitor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
    • A61L27/3843—Connective tissue
    • A61L27/3847—Bones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
    • A61L27/3843—Connective tissue
    • A61L27/3852—Cartilage, e.g. meniscus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3895—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells using specific culture conditions, e.g. stimulating differentiation of stem cells, pulsatile flow conditions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0654—Osteocytes, Osteoblasts, Odontocytes; Bones, Teeth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/15—Transforming growth factor beta (TGF-β)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/54—Collagen; Gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Rheumatology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Vascular Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Composición para la reparación ósea y cartilaginosa que comprende un conjunto de células madre mesenquimáticas humanas diferenciadas hacia el linaje condroosteogénico, mediante su amplificación con suero humano y un factor de crecimiento transformante beta 1 con un dominio molecular de unión al colágeno I (TGF-ß1-DUC) obtenido en sistemas de expresión eucarióticos, y un material biocompatible al que se absorben las células así procesadas. Esta composición puede usarse mediante implantes en la zona a reparar o directamente por inyección de las células en suspensión, bien en el lugar de la lesión o incluso en la circulación sistémica para procurar su distribución generalizada.
PCT/ES2005/000287 2004-05-21 2005-05-20 Composición para la reparación ósea y cartilaginosa WO2005112542A2 (es)

Priority Applications (9)

Application Number Priority Date Filing Date Title
MXPA06013492A MXPA06013492A (es) 2004-05-21 2005-05-20 Composicion para la reparacion osea y cartilaginosa.
AU2005244626A AU2005244626A1 (en) 2004-05-21 2005-05-20 Cartilage and bone repair composition
JP2007517309A JP2007538055A (ja) 2004-05-21 2005-05-20 軟骨および骨修復用組成物
US11/597,236 US20080031915A1 (en) 2004-05-21 2005-05-20 Cartilage and Bone Repair Composition
BRPI0510829-2A BRPI0510829A (pt) 2004-05-21 2005-05-20 uso de células tronco mesenquimáticas humanas, procedimento de capacitação in vitro de células condro-osteogênicas a partir de células tronco mesenquimáticas humanas, células com capacidade condro-osteogênica, uso de células com capacidade condro-osteogênica e composição capaz de induzir osteogênesis
EP05750573A EP1760144A2 (en) 2004-05-21 2005-05-20 Cartilage and bone repair composition
NZ552180A NZ552180A (en) 2004-05-21 2005-05-20 Cartilage and bone repair composition comprising human mesenchymal stem cells
CA002567314A CA2567314A1 (en) 2004-05-21 2005-05-20 Cartilage and bone repair composition
IL179442A IL179442A0 (en) 2004-05-21 2006-11-21 Cartilage and bone repair composition

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ESP200401227 2004-05-21
ES200401227A ES2245879B1 (es) 2004-05-21 2004-05-21 Composicion para la reparacion osea o cartilaginosa.

Publications (2)

Publication Number Publication Date
WO2005112542A2 WO2005112542A2 (es) 2005-12-01
WO2005112542A3 true WO2005112542A3 (es) 2006-03-23

Family

ID=35428711

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/ES2005/000287 WO2005112542A2 (es) 2004-05-21 2005-05-20 Composición para la reparación ósea y cartilaginosa

Country Status (14)

Country Link
US (1) US20080031915A1 (es)
EP (1) EP1760144A2 (es)
JP (1) JP2007538055A (es)
KR (1) KR20070047740A (es)
CN (1) CN101014701A (es)
AU (1) AU2005244626A1 (es)
BR (1) BRPI0510829A (es)
CA (1) CA2567314A1 (es)
ES (1) ES2245879B1 (es)
IL (1) IL179442A0 (es)
MX (1) MXPA06013492A (es)
NZ (1) NZ552180A (es)
RU (1) RU2375447C2 (es)
WO (1) WO2005112542A2 (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050064042A1 (en) * 2003-04-29 2005-03-24 Musculoskeletal Transplant Foundation Cartilage implant plug with fibrin glue and method for implantation
US7067123B2 (en) 2003-04-29 2006-06-27 Musculoskeletal Transplant Foundation Glue for cartilage repair
US20050222687A1 (en) * 2004-04-02 2005-10-06 Gordana Vunjak-Novakovic Cartilage implant assembly and method for implantation
US7901457B2 (en) * 2003-05-16 2011-03-08 Musculoskeletal Transplant Foundation Cartilage allograft plug
US20080220044A1 (en) * 2007-03-06 2008-09-11 Semler Eric J Cancellous construct with support ring for repair of osteochondral defects
US20090319045A1 (en) 2004-10-12 2009-12-24 Truncale Katherine G Cancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles
US7837740B2 (en) * 2007-01-24 2010-11-23 Musculoskeletal Transplant Foundation Two piece cancellous construct for cartilage repair
US7815926B2 (en) * 2005-07-11 2010-10-19 Musculoskeletal Transplant Foundation Implant for articular cartilage repair
EP1926459B1 (en) 2005-09-19 2015-01-07 Histogenics Corporation Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof
CZ301148B6 (cs) * 2006-01-25 2009-11-18 Univerzita Karlova V Praze Zpusob pestování lidských mezenchymových kmenových bunek, zejména pro lécbu nehojících se fraktur, a bioreaktor k provádení tohoto zpusobu
US8435551B2 (en) * 2007-03-06 2013-05-07 Musculoskeletal Transplant Foundation Cancellous construct with support ring for repair of osteochondral defects
EP2137300B1 (en) 2007-04-26 2011-10-26 Ramot at Tel-Aviv University Ltd. Pluripotent autologous stem cells from oral or gastrointestinal mucosa
US8062364B1 (en) 2007-04-27 2011-11-22 Knee Creations, Llc Osteoarthritis treatment and device
EP2344631B1 (en) 2008-10-31 2019-10-16 Synthes GmbH Method and device for activating stem cells
WO2011054359A2 (en) 2009-11-06 2011-05-12 University Of Copenhagen Method for early detection of cancer
CN101705208B (zh) * 2009-12-15 2012-05-02 北京科润维德生物技术有限责任公司 将人羊膜间充质细胞诱导分化成骨或软骨细胞的方法
CN102971414B (zh) * 2009-12-22 2016-01-27 新加坡科技研究局 骨折的治疗
US8574614B2 (en) * 2010-02-04 2013-11-05 Hwa-Chang Liu Surgical grafts for repairing chondral defects
RU2456927C2 (ru) * 2010-10-13 2012-07-27 Федеральное государственное учреждение "Российский научный центр "Восстановительная травматология и ортопедия" имени академика Г.А. Илизарова" Министерства здравоохранения и социального развития Российской Федерации ФГУ "РНЦ "ВТО" им. акад. Г.А. Илизарова Способ биологической оценки остеоиндуцирующего эффекта белков плазмы крови
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container
CN107224618A (zh) * 2016-03-25 2017-10-03 中国科学院苏州纳米技术与纳米仿生研究所 促进骨再生的活性支架材料、其制备方法及应用
AU2017204355B2 (en) 2016-07-08 2021-09-09 Mako Surgical Corp. Scaffold for alloprosthetic composite implant
CN108578777B (zh) * 2018-05-06 2021-05-07 西北工业大学 一种生长因子浓度梯度可控的人工硬骨支架制备方法

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
ANDRADES J A ET AL: "A modified rhTGF-beta1 and rhBMP-2 are effective in initiating a chondro-osseous differentiation pathway in bone marrow cells cultured in vitro.", CONNECT TISSUE RES., vol. 44, no. 3-4, 2003, pages 188 - 197, XP008074689 *
ANDRADES J A ET AL: "A recombinant human TGF-beta1 fusion protein with collagen-binding domain promotes migration, growth, and differentiation of bone marrow mesenchymal cells.", EXP CELL RES., vol. 250, no. 2, 1 August 1999 (1999-08-01), pages 485 - 498, XP002906294 *
BECERRA J ET AL: "Bone regeneration, cell therapy and tissue engineering.", MED CLIN., vol. 116, no. 1, 13 January 2001 (2001-01-13), pages 23 - 34, XP008074694 *
GORDON E M ET AL: "Capture and expansion of bone marrow-derived mesenchymal progenitor cells with a transforming growth factor-beta1-von Willebrand's factor fusion protein for retrovirus-mediated delivery of coagulation factor IX.", HUM GENE THER., vol. 8, no. 11, 20 July 1997 (1997-07-20), pages 1385 - 1394, XP002922940 *
MURAGLIA A ET AL: "Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model.", J CELL SCI., vol. 113, no. 7, April 2000 (2000-04-01), pages 1161 - 1166, XP002205333 *

Also Published As

Publication number Publication date
ES2245879B1 (es) 2006-12-16
US20080031915A1 (en) 2008-02-07
BRPI0510829A (pt) 2007-11-27
RU2375447C2 (ru) 2009-12-10
CN101014701A (zh) 2007-08-08
EP1760144A2 (en) 2007-03-07
AU2005244626A1 (en) 2005-12-01
WO2005112542A2 (es) 2005-12-01
ES2245879A1 (es) 2006-01-16
CA2567314A1 (en) 2005-12-01
RU2006145431A (ru) 2008-06-27
KR20070047740A (ko) 2007-05-07
JP2007538055A (ja) 2007-12-27
NZ552180A (en) 2009-11-27
IL179442A0 (en) 2007-05-15
MXPA06013492A (es) 2007-01-23

Similar Documents

Publication Publication Date Title
WO2005112542A3 (es) Composición para la reparación ósea y cartilaginosa
WO2005081870A3 (en) Intervertebral disc repair, methods and devices therefor
WO2007035843A3 (en) Methods and compositions for organ and tissue functionality
WO2006033103A3 (en) Compositions and methods for stem cell expansion and differentiation
WO2007008250A3 (en) Biomaterials for guided tissue regeneration and target drug delivery
ATE543509T1 (de) Material und verfahren zur förderung der reparatur von nervengewebe
NZ527565A (en) Methods and devices for tissue repair
WO2003040346A3 (en) Methods and compositions for the use of stromal cells to support embryonic and adult stem cells
TW200503794A (en) Treatment of tissue with undifferentiated mesenchymal cells
WO2007062082A3 (en) Method and composition for repair and reconstruction of intervertebral discs and other reconstructive surgery
WO2006027622A3 (en) Transglutaminase crosslinked collagen biomaterial for medical implant materials
WO1999038952A3 (en) Cells or tissues with increased protein factors and methods of making and using same
WO2005086849A3 (en) Implant scaffold combined with autologous or allogenic tissue
EP2420568A3 (en) Methods and compositions for treatment of bone defects with placental cell populations
DE60007079D1 (de) Methoden und zusammensetzungen zur heilung und reparatur von gelenkknorpeln
WO2005077013A3 (en) Surface directed cellular attachment
BR0213805A (pt) Células estromais derivadas de tecido adiposo para diferenciação endócrina do pâncreas e usos das mesmas
WO2007035363A3 (en) Compositions and methods for the augmentation and repair of defects in tissue
WO2004047747A3 (en) Compositions and methods for cell dedifferentiation and tissue regeneration
WO2006081435A3 (en) Method of providing readily available cellular material derived from cord blood, and a composition thereof
WO2008058233A3 (en) In vivo bioreactors and methods of making and using same
WO2003025167A3 (en) Cultured stromal cells and uses thereof
ATE454910T1 (de) Zusammengesetzte strukturen mit hyaluronsäure und derivaten davon als neue knochensubstitute und transplantate
WO2008011524A3 (en) Method of using mitotically inactivated stem cells for damaged tissue repair
ATE255920T1 (de) Methoden und zusammensetzungen zur heilung und reparatur von gelenkknorpeln

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DPEN Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2567314

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: PA/a/2006/013492

Country of ref document: MX

Ref document number: 179442

Country of ref document: IL

Ref document number: 2007517309

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Ref document number: DE

WWE Wipo information: entry into national phase

Ref document number: 552180

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 2005244626

Country of ref document: AU

Ref document number: 7748/DELNP/2006

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 2005750573

Country of ref document: EP

Ref document number: 2006145431

Country of ref document: RU

Ref document number: 1020067026980

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 200580023059.1

Country of ref document: CN

ENP Entry into the national phase

Ref document number: 2005244626

Country of ref document: AU

Date of ref document: 20050520

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2005244626

Country of ref document: AU

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWP Wipo information: published in national office

Ref document number: 2005750573

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 11597236

Country of ref document: US

ENP Entry into the national phase

Ref document number: PI0510829

Country of ref document: BR

WWP Wipo information: published in national office

Ref document number: 11597236

Country of ref document: US